NuCana plc (NCNA:NASDAQ) closed at $0.961 on November 9, 2026, up 2.44% on the day. The stock trades 78.9% below its 52-week high of $4.55 and 6.7% above its 52-week low of $0.900. Over the past year, it lost 73.8%. NuCana plc is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 7, 2025, NCNA closed higher on 101 days (40%). Its best day was April 7, 2026 (+22.02%) and its worst was August 31, 2026 (-16.48%). The stock moved 10% or more in a single session 10 times.
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Find more stocks like NCNA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.